176 related articles for article (PubMed ID: 9667643)
1. 31P-magnetic resonance spectroscopy and 2H-magnetic resonance imaging studies of a panel of early-generation transplanted murine tumour models.
Robinson SP; van den Boogaart A; Maxwell RJ; Griffiths JR; Hamilton E; Waterton JC
Br J Cancer; 1998 Jun; 77(11):1752-60. PubMed ID: 9667643
[TBL] [Abstract][Full Text] [Related]
2. The combined measurement of blood flow and metabolism in RIF-1 tumours in vivo. A study using H2 flow and 31P NMR spectroscopy.
Bhujwalla ZM; Tozer GM; Field SB; Proctor E; Busza A; Williams SR
NMR Biomed; 1990 Aug; 3(4):178-83. PubMed ID: 2206850
[TBL] [Abstract][Full Text] [Related]
3. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study.
Dunn JF; Frostick S; Adams GE; Stratford IJ; Howells N; Hogan G; Radda GK
FEBS Lett; 1989 Jun; 249(2):343-7. PubMed ID: 2737292
[TBL] [Abstract][Full Text] [Related]
4. Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.
Tozer GM; Maxwell RJ; Griffiths JR; Pham P
Br J Cancer; 1990 Oct; 62(4):553-60. PubMed ID: 2223572
[TBL] [Abstract][Full Text] [Related]
5. Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
Nordsmark M; Maxwell RJ; Wood PJ; Stratford IJ; Adams GE; Overgaard J; Horsman MR
Br J Cancer Suppl; 1996 Jul; 27():S232-5. PubMed ID: 8763887
[TBL] [Abstract][Full Text] [Related]
6. Spatial heterogeneity of the metabolic response of RIF-1 tumors to a vasoactive agent evaluated in vivo by one-dimensional 31P chemical-shift imaging.
Bhujwalla ZM; Blackband SJ; Wehrle JP; Glickson JD
Magn Reson Med; 1992 Aug; 26(2):308-12. PubMed ID: 1513252
[TBL] [Abstract][Full Text] [Related]
7. Differences in vascular response between primary and transplanted tumours.
Field SB; Needham S; Burney IA; Maxwell RJ; Coggle JE; Griffiths JR
Br J Cancer; 1991 May; 63(5):723-6. PubMed ID: 1645562
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status.
Beauregard DA; Thelwall PE; Chaplin DJ; Hill SA; Adams GE; Brindle KM
Br J Cancer; 1998 Jun; 77(11):1761-7. PubMed ID: 9667644
[TBL] [Abstract][Full Text] [Related]
9. Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.
Newell K; Wood P; Stratford I; Tannock I
Br J Cancer; 1992 Aug; 66(2):311-7. PubMed ID: 1503904
[TBL] [Abstract][Full Text] [Related]
10. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK
Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606
[TBL] [Abstract][Full Text] [Related]
11. The energy metabolism of RIF-1 tumours following hydralazine.
Bhujwalla ZM; Tozer GM; Field SB; Maxwell RJ; Griffiths JR
Radiother Oncol; 1990 Nov; 19(3):281-91. PubMed ID: 2281156
[TBL] [Abstract][Full Text] [Related]
12. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
Lyng H; Olsen DR; Southon TE; Rofstad EK
Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of thermal damage after hyperthermia on murine experimental tumor by 31P-NMR spectroscopy--correlation between ATP and growth delay.
Kitada N; Akagi K; Tanaka Y; Fritz-Zieroth B
J Radiat Res; 1994 Jun; 35(2):65-73. PubMed ID: 7965991
[TBL] [Abstract][Full Text] [Related]
14. The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours.
McCoy CL; Parkins CS; Chaplin DJ; Griffiths JR; Rodrigues LM; Stubbs M
Br J Cancer; 1995 Oct; 72(4):905-11. PubMed ID: 7547238
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
16. An assessment of artefacts in localized and non-localized 31P MRS studies of phosphate metabolites and pH in rat tumours.
Howe FA; Stubbs M; Rodrigues LM; Griffiths JR
NMR Biomed; 1993; 6(1):43-52. PubMed ID: 8457426
[TBL] [Abstract][Full Text] [Related]
17. Nonglycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy.
Hwang YY; Kim SG; Evelhoch JL; Ackerman JJ
Cancer Res; 1992 Mar; 52(5):1259-66. PubMed ID: 1737388
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
Aboagye EO; Dillehay LE; Bhujwalla ZM; Lee DJ
Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940
[TBL] [Abstract][Full Text] [Related]
19. [Study of anti-tumor effects of hyperthermia combined with hydralazine on experimental tumor].
Aoki Y; Akagi K; Kitada N; Tanaka Y; Fritz-Zieroth B
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):987-92. PubMed ID: 8570396
[TBL] [Abstract][Full Text] [Related]
20. The response of spontaneous and transplantable murine tumors to vasoactive agents measured by 31P magnetic resonance spectroscopy.
Wood PJ; Stratford IJ; Sansom JM; Cattanach BM; Quinney RM; Adams GE
Int J Radiat Oncol Biol Phys; 1992; 22(3):473-6. PubMed ID: 1735681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
